JPS5665828A - Antitumor agent - Google Patents

Antitumor agent

Info

Publication number
JPS5665828A
JPS5665828A JP14215279A JP14215279A JPS5665828A JP S5665828 A JPS5665828 A JP S5665828A JP 14215279 A JP14215279 A JP 14215279A JP 14215279 A JP14215279 A JP 14215279A JP S5665828 A JPS5665828 A JP S5665828A
Authority
JP
Japan
Prior art keywords
agent
antibody
purity
tumor
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14215279A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6256136B2 (enrdf_load_stackoverflow
Inventor
Chikao Yoshikumi
Takami Fujii
Masahiko Fujii
Kenichi Matsunaga
Yoshiharu Oguchi
Koichi Niimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP14215279A priority Critical patent/JPS5665828A/ja
Priority to US06/103,474 priority patent/US4315851A/en
Priority to SE7910483A priority patent/SE7910483L/xx
Priority to PH23447A priority patent/PH16902A/en
Priority to GB7944494A priority patent/GB2038836B/en
Priority to FR797932054A priority patent/FR2445149B1/fr
Priority to CH11501/79A priority patent/CH655010A5/de
Priority to DE2952690A priority patent/DE2952690C2/de
Priority to IT28464/79A priority patent/IT1127324B/it
Publication of JPS5665828A publication Critical patent/JPS5665828A/ja
Priority to US06/321,486 priority patent/US4401592A/en
Priority to SE8406510A priority patent/SE8406510D0/xx
Priority to SE8406511A priority patent/SE8406511D0/xx
Publication of JPS6256136B2 publication Critical patent/JPS6256136B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP14215279A 1978-12-29 1979-11-02 Antitumor agent Granted JPS5665828A (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP14215279A JPS5665828A (en) 1979-11-02 1979-11-02 Antitumor agent
US06/103,474 US4315851A (en) 1978-12-29 1979-12-14 Pharmaceutical composition having antitumor activity
SE7910483A SE7910483L (sv) 1978-12-29 1979-12-19 Farmaceutisk komposition med tumorhemmande effekt
PH23447A PH16902A (en) 1978-12-29 1979-12-20 Pharmaceutical composition having anti-tumor activity
GB7944494A GB2038836B (en) 1978-12-29 1979-12-28 Antitumour substance
FR797932054A FR2445149B1 (fr) 1978-12-29 1979-12-28 Composition pharmaceutique ayant une activite antitumorale
CH11501/79A CH655010A5 (de) 1978-12-29 1979-12-28 Pharmazeutischer wirkstoff mit antitumoraktivitaet.
DE2952690A DE2952690C2 (de) 1978-12-29 1979-12-29 Antitumorsubstanz, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Mittel
IT28464/79A IT1127324B (it) 1978-12-29 1979-12-31 Composizione farmaceutica avente attivita' antitumorale
US06/321,486 US4401592A (en) 1978-12-29 1981-11-16 Pharmaceutical composition having antitumor activity
SE8406510A SE8406510D0 (sv) 1978-12-29 1984-12-20 Farmaceutisk komposition med tumorhemmande effekt
SE8406511A SE8406511D0 (sv) 1978-12-29 1984-12-20 Farmaceutisk komposition med tumorhemmande effekt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14215279A JPS5665828A (en) 1979-11-02 1979-11-02 Antitumor agent

Publications (2)

Publication Number Publication Date
JPS5665828A true JPS5665828A (en) 1981-06-03
JPS6256136B2 JPS6256136B2 (enrdf_load_stackoverflow) 1987-11-24

Family

ID=15308563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14215279A Granted JPS5665828A (en) 1978-12-29 1979-11-02 Antitumor agent

Country Status (1)

Country Link
JP (1) JPS5665828A (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58118520A (ja) * 1982-01-09 1983-07-14 Hidematsu Hirai 抗腫瘍性蛋白複合体およびその製造法
JPS62142123A (ja) * 1983-04-08 1987-06-25 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0470125U (enrdf_load_stackoverflow) * 1990-10-25 1992-06-22

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4962194A (enrdf_load_stackoverflow) * 1972-05-10 1974-06-17
JPS5161640A (en) * 1974-09-20 1976-05-28 Searle & Co Koshuyozaino seizoho
JPS51144723A (en) * 1975-05-27 1976-12-13 Yeda Res & Dev Antiitumor agent
JPS5592325A (en) * 1978-12-29 1980-07-12 Kureha Chem Ind Co Ltd Antitumor agent and its preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4962194A (enrdf_load_stackoverflow) * 1972-05-10 1974-06-17
JPS5161640A (en) * 1974-09-20 1976-05-28 Searle & Co Koshuyozaino seizoho
JPS51144723A (en) * 1975-05-27 1976-12-13 Yeda Res & Dev Antiitumor agent
JPS5592325A (en) * 1978-12-29 1980-07-12 Kureha Chem Ind Co Ltd Antitumor agent and its preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58118520A (ja) * 1982-01-09 1983-07-14 Hidematsu Hirai 抗腫瘍性蛋白複合体およびその製造法
JPS62142123A (ja) * 1983-04-08 1987-06-25 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤

Also Published As

Publication number Publication date
JPS6256136B2 (enrdf_load_stackoverflow) 1987-11-24

Similar Documents

Publication Publication Date Title
IT8223795A0 (it) Gamma), relativi veicoli di polipeptidi contenenti la sequenza espressione, loro procedimento di degli amminoacidi dell'interferone preparazione, composizioni umano immune (interferone umano farmaceutiche contenenti tali polipeptidi.
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
DK0458878T3 (da) Nyt monoklonalt antistof mod et nyt antigen, der er associeret med humane tumorer
ES521741A0 (es) Procedimiento para la preparacion de nuevos aminoacidos biciclicos.
ES521656A0 (es) Procedimiento para la preparacion de aminoacidos biciclicos.
EP0536275A4 (en) Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
DE69324487D1 (de) Rezeptorbindende region des diphtherietoxius
EP0261224A4 (en) SYNTHETIC HTLV III PEPTIDE COMPOSITIONS AND THEIR USE.
NZ213535A (en) Purified polyclonal antibody that binds selectively to the marker epitope encompassing amino acid position 12 of an activated form of oncogenic p21 protein
IL68201A0 (en) Peptides with the specificity of foot and mouth disease viral antigens and compositions and methods for treating animals using the same
ES2071628T3 (es) Separacion de proteina a de preparaciones de anticuerpos.
NL191583C (nl) Voorprodukten voor essentiële en semi-essentiële aminozuren in het lichaam en werkwijze voor de bereiding van deze voorprodukten.
EP0674661A4 (en) TITRATION AND TREATMENT FOR DEMYELINIZING DISEASES SUCH AS MULTIPLE SCLEROSIS.
IT8319160A0 (it) Procedimento di sintesi di peptidi e agenti di bloccaggio di amminoacidi.
DE69126577D1 (de) Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung
JPS5665828A (en) Antitumor agent
ZA833483B (en) In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
ES8704082A1 (es) Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa.
JPS5665829A (en) Antitumor agent
EP0412970A4 (en) Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
EP0530216A4 (en) Administration of monoclonal antibodies against respiratory viruses
FR2315916A2 (fr) Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree
JPS5592325A (en) Antitumor agent and its preparation
NL7902971A (nl) Werkwijze voor de bereiding van asymmetrisch n-fenyl-n'-gesubstitueerd p-fenyldiamine.
Stein et al. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe extracts